| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |